Monitor stock price reaction to the dilutive offering; watch for registration statement filing and potential selling by the investor post-registration. The premium pricing ($4.80) suggests some support, but the 5-year warrant overhang may cap upside.
Price Chart
Executive Summary
Pulsenmore priced a $7.5M private placement of 1,562,500 ordinary shares (or pre-funded warrants) and 1,562,500 five-year ordinary warrants at $4.80 per unit to a single healthcare-focused institutional investor. The offering will dilute existing shareholders by ~[unknown]% while providing cash for marketing and commercialization. The warrants are exercisable at $4.80, creating potential future overhang.
Key Facts
- Gross proceeds ~$7.5 million from sale of 1,562,500 ordinary shares (or pre-funded warrants) and 1,562,500 ordinary warrants
- Combined purchase price $4.80 per share/warrant unit; ordinary warrants exercisable at $4.80 for 5 years
- Use of proceeds: marketing, commercialization, working capital
- A.G.P./Alliance Global Partners acting as placement agent with 7% cash fee
- Closing expected June 26, 2026 subject to customary conditions
Financial Impact
Dilution of approximately [unknown]% based on current outstanding shares (not provided); $7.5M gross proceeds
Risk Factors
- Significant dilution to existing shareholders
- Warrant overhang may pressure stock price
- Execution risk on commercialization plans with new capital
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001493152-26-030145 |
| Exhibit: ex10-2.htm | 0001493152-26-030145 |
| Exhibit: ex10-3.htm | 0001493152-26-030145 |
| Exhibit: ex10-4.htm | 0001493152-26-030145 |
| Exhibit: ex99-1.htm | 0001493152-26-030145 |
| Document: form6-k.htm | 0001493152-26-030145 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | 6-K | $1.90 | awaiting T+20 | — | $1.77 (−6.84%) |
Oct 8, 2026 18d ago | SC 13G | $1.85 | awaiting T+20 | — | $1.77 (−4.32%) |
Sep 17, 2026 5w ago | 6-K | $2.42 $1.81 | ▼ −25.21% | ▼ −26.41% | $1.77 (−26.86%) |
Sep 8, 2026 6w ago | 6-K | $2.46 $2.16 | ▼ −12.20% | ▼ −13.91% | $1.77 (−28.05%) |
Sep 2, 2026 7w ago | EFFECT | $2.55 $2.22 | ▲ +12.94% | ▲ +12.86% | $1.77 (+30.59%) |
Aug 31, 2026 8w ago | 6-K | $2.62 $2.19 | ▼ −16.41% | ▼ −16.22% | $1.77 (−32.44%) |
Aug 19, 2026 9w ago | 6-K | $3.01 $2.42 | ▼ −19.60% | ▼ −18.76% | $1.77 (−41.20%) |
Aug 17, 2026 10w ago | 6-K | $2.89 $2.41 | ▼ −16.61% | ▼ −14.63% | $1.77 (−38.75%) |
Jul 13, 2026 15w ago | 6-K | $3.62 $3.26 | ▼ −9.94% | ▼ −13.13% | $1.77 (−51.10%) |
Jul 13, 2026 15w ago | EFFECT | $3.62 $3.26 | ▼ −9.94% | ▼ −13.13% | $1.77 (−51.10%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers